Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten... -- NEW ORLEANS, May 26 /PRNewswire-FirstCall/ --
Links shared publicly online about this topic.
- 1,138total visits
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten... -- NEW ORLEANS, May 26 /PRNewswire-FirstCall/ --
Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder. Additional Phase 3 Analyses and Phase 1 Cardiovascular Safety Data Presented by Alexza Pharmaceuticals at the American Psychiatric Association 2010 Annual Meeting.
View full resource at prnewswire.com
Tags: Heart, Bipolar Disorder, Schizophrenia, Psychotic Disorder, Disease and Condition, Pharma, Safety
Most Recently Shared on May 27, 2010 at 10:04 am By:
Dr Stephen Ayer - Schizophrenia Society of Nova Scotia
Loxapine Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with SZ or BD: http://goo.gl/EKdE
Advertisement
